Global markets have recently experienced turbulence, with U.S. stock indexes posting losses amid renewed tariffs and trade policy uncertainty, compounded by weaker economic data and a slowing labor market. For investors willing to explore beyond the major indices, penny stocks—often representing smaller or newer companies—can still present intriguing opportunities. Despite being a somewhat outdated term, penny stocks remain relevant as they can offer surprising value and potential growth when backed by solid financial health.

Top 10 Penny Stocks Globally

Name Share Price Market Cap Financial Health Rating EZZ Life Science Holdings (ASX:EZZ) A$2.08 A$96.71M ★★★★★★ Lever Style (SEHK:1346) HK$1.47 HK$921.19M ★★★★★★ GTN (ASX:GTN) A$0.385 A$74.36M ★★★★★★ TK Group (Holdings) (SEHK:2283) HK$2.38 HK$1.92B ★★★★★★ Angler Gaming (NGM:ANGL) SEK3.60 SEK269.95M ★★★★★★ CNMC Goldmine Holdings (Catalist:5TP) SGD0.54 SGD218.86M ★★★★★☆ MGB Berhad (KLSE:MGB) MYR0.515 MYR304.7M ★★★★★★ Yangzijiang Shipbuilding (Holdings) (SGX:BS6) SGD2.57 SGD10.11B ★★★★★☆ Begbies Traynor Group (AIM:BEG) £1.235 £196.53M ★★★★★★ Netgem (ENXTPA:ALNTG) €0.944 €31.84M ★★★★★★

Click here to see the full list of 3,824 stocks from our Global Penny Stocks screener.

We're going to check out a few of the best picks from our screener tool.

Zhejiang Dongwang Times Technology

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Zhejiang Dongwang Times Technology Co., Ltd. operates in China, offering energy-saving services and film and television culture solutions, with a market cap of CN¥3.59 billion.

Operations: The company's revenue is primarily derived from its operations in China, amounting to CN¥511.79 million.

Market Cap: CN¥3.59B

Zhejiang Dongwang Times Technology, operating with a market cap of CN¥3.59 billion, remains unprofitable despite generating CN¥511.79 million in revenue from its energy-saving and cultural solutions in China. The company's short-term assets of CN¥1.1 billion comfortably cover both short-term and long-term liabilities, indicating solid liquidity management. Despite an increased debt-to-equity ratio to 3% over five years, the company maintains more cash than total debt and covers interest payments effectively through its operating cash flow. However, earnings have declined significantly over the past five years by 49% annually, reflecting ongoing financial challenges amidst stable weekly volatility.

Take a closer look at Zhejiang Dongwang Times Technology's potential here in our financial health report. Assess Zhejiang Dongwang Times Technology's previous results with our detailed historical performance reports.

Story Continues

SHSE:600052 Revenue & Expenses Breakdown as at Aug 2025

Harbin VITI Electronics

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Harbin VITI Electronics Co., Ltd. is engaged in the research, development, manufacturing, and sale of automobile electronic products for cars and buses in China, with a market cap of CN¥2.22 billion.

Operations: The company's revenue segment is primarily from Computer Communications and Other Electronic Equipment Manufacturing, generating CN¥82.86 million.

Market Cap: CN¥2.22B

Harbin VITI Electronics Co., Ltd., with a market cap of CN¥2.22 billion, has transitioned to profitability recently, marking a significant milestone in its financial journey. The company operates without debt, alleviating concerns about interest coverage and showcasing strong liquidity with short-term assets of CN¥691.1 million exceeding both short-term and long-term liabilities. Despite the positive shift to profitability, past earnings have declined by 52.4% annually over five years, highlighting challenges in sustaining growth momentum. Additionally, recent financial results were impacted by a large one-off gain of CN¥719.3K, which may not reflect ongoing operational performance accurately.

Dive into the specifics of Harbin VITI Electronics here with our thorough balance sheet health report. Learn about Harbin VITI Electronics' historical performance here.SHSE:603023 Financial Position Analysis as at Aug 2025

Shenzhen Glory MedicalLtd

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Shenzhen Glory Medical Co., Ltd. offers hospital construction and medical system integrated solutions both in China and internationally, with a market cap of CN¥3.34 billion.

Operations: Shenzhen Glory Medical Co., Ltd. has not reported specific revenue segments.

Market Cap: CN¥3.34B

Shenzhen Glory Medical Co., Ltd., with a market cap of CN¥3.34 billion, has recently achieved profitability, though its past earnings have declined significantly by 46.5% annually over five years. The company's financial health is supported by strong liquidity, as short-term assets of CN¥1.7 billion comfortably cover both short and long-term liabilities. Despite low return on equity at 0.9%, the firm benefits from high-quality earnings and a reduced debt-to-equity ratio from 12.3% to 2.5% over five years, indicating improved financial management and stability in interest coverage with more cash than total debt.

Click here and access our complete financial health analysis report to understand the dynamics of Shenzhen Glory MedicalLtd. Review our historical performance report to gain insights into Shenzhen Glory MedicalLtd's track record.SZSE:002551 Revenue & Expenses Breakdown as at Aug 2025

Where To Now?

Reveal the 3,824 hidden gems among our  Global Penny Stocks screener with a single click here. Ready For A Different Approach? The end of cancer? These 25 emerging AI stocks are developing tech that will allow early idenification of life changing disesaes like cancer and Alzheimer's.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include SHSE:600052 SHSE:603023 and SZSE:002551.

This article was originally published by Simply Wall St.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]

View Comments